Vident Advisory, LLC Pacific Biosciences Of California, Inc. Transaction History

Vident Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $125,835 - $337,719	92,526 Added 572.77%	108,680 $149 Million
Q1 2024 May 14, 2024	SELL	$3.52 - $9.59 $53,359 - $145,374	-15,159 Reduced 48.41%	16,154 $60.6 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $48,828 - $84,734	8,179 Added 35.35%	31,313 $307 Million
Q3 2023 Feb 21, 2024	SELL	$8.23 - $13.93 $67,313 - $113,933	-8,179 Reduced 26.12%	23,134 $193 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $190,392 - $322,256	23,134 New	23,134 $193 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.